MRI diagnosis of saccular hydrops: Comparison of heavily-T2 FIESTA-C and 3D-FLAIR sequences with delayed acquisition.


Journal

Journal of neuroradiology = Journal de neuroradiologie
ISSN: 0150-9861
Titre abrégé: J Neuroradiol
Pays: France
ID NLM: 7705086

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 04 01 2019
revised: 19 02 2019
accepted: 12 04 2019
pubmed: 30 4 2019
medline: 26 11 2021
entrez: 30 4 2019
Statut: ppublish

Résumé

Currently, 3D-FLAIR sequence performed 4hours after the intravenous administration of a single dose of contrast media is the imaging technique of choice for the diagnosis of saccular hydrops (SH). Recently, the diagnosis of SH has also been reported with heavily-T2 weighted sequences. In this retrospective imaging study, we performed 3D-FLAIR sequences 4hours after contrast media administration and 3D FIESTA-C sequences before and 4hours after contrast media administration in 30 patients with unilateral definite, probable or possible clinical diagnosis of Menière's disease (MD). Two radiologists, blinded to the clinical data, independently assessed the presence of saccular hydrops. Inter-reader agreement tests were performed. On delayed post-contrast 3D-FLAIR sequence, 15 patients out of 30 referred with a SH that was never seen on the controlateral asymptomatic side. The specificity and the sensitivity to detect MD side were 100% and 50% respectively. On non-enhanced 3D FIESTA-C sequence, 16 patients out of 30 (53%) referred with a saccular hydrops that was observed in 6 patients on the clinical asymptomatic ear. The specificity and the sensitivity to detect MD side were 80% and 33% respectively. On delayed 3D FIESTA-C sequence, 13 patients out of 30 (43%) referred with a saccular hydrops that was seen in 4 patients on the controlateral asymptomatic side. The specificity and the sensitivity to detect MD side were 83% and 27% respectively. Delayed post-contrast 3D-FLAIR is highly specific of MD symptoms while 3D FIESTA-C sequences are less sensitive and specific for the diagnosis of SH.

Identifiants

pubmed: 31034895
pii: S0150-9861(19)30002-1
doi: 10.1016/j.neurad.2019.04.005
pii:
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

446-452

Informations de copyright

Copyright © 2019. Published by Elsevier Masson SAS.

Auteurs

Michael Eliezer (M)

Department of Neuroradiology and MRI, Rouen University Hospital, Rouen, France. Electronic address: mcheliezer@gmail.com.

Guillaume Poillon (G)

Department of Neuroradiology and MRI, Rouen University Hospital, Rouen, France.

Julien Horion (J)

Department of Neuroradiology and MRI, Rouen University Hospital, Rouen, France.

Phillipe Lelion (P)

Department of Head and Neck Surgery, Rouen University Hospital, Rouen, France.

Emmanuel Gerardin (E)

Department of Neuroradiology and MRI, Rouen University Hospital, Rouen, France.

Nicolas Magne (N)

Department of Neuroradiology and MRI, Rouen University Hospital, Rouen, France.

André Gillibert (A)

Department of Biostatistics, Rouen University Hospital, Rouen, France.

Arnaud Attyé (A)

Department of Neuroradiology and MRI, Rouen University Hospital, Rouen, France; Department of Neuroradiology and MRI, Grenoble Alpes University Hospital - SFR RMN Neurosciences, Grenoble, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH